Stay updated on Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.

Latest updates to the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page
- Check4 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check10 days agoChange DetectedA site-wide notice announces updates to NIH websites and says federal agencies are transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.7%

- Check18 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check24 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry 'Revision: v3.7.0' has been added to the record history, signaling an updated version of the page. The previous revision 'Revision: v3.6.6' has been removed from the history.SummaryDifference0.1%

- Check67 days agoChange DetectedA new Revision: v3.6.6 appears in the record history, replacing the previous v3.6.5. This update represents a metadata version change to the study record and does not alter the study data or eligibility information.SummaryDifference0.1%

Stay in the know with updates to Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.